New chewable drug for hookworm, roundworm and whipworm
Part of Infections clinical trials.
This trial tests a new chewable tablet (ZP5-9676) to treat common intestinal worm infections. It compares the new drug to a placebo (fake pill) to see if it's safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be between 6 months and 59 years old.
- You must live in an area where hookworm, roundworm, or whipworm infections are common.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of medicines works better than a single medicine to treat common intestinal worms (like hookworm and roundworm) in young children in Bangladesh. It is for children who are either stunted (shorter than average for their age) or healthy, and who have a confirmed worm infection.
This study tests a new medicine, emodepside, to see how well it treats infections with intestinal worms like whipworm, hookworm, and roundworm. It may help people who have not been cured by current treatments.
This study tests different combinations of medicines to treat whipworm infection in children. It aims to find the best way to clear the infection and improve children's health.
This study tests a medication called oxfendazole to see if it can get rid of whipworm infection in adults. Participants take the medication and provide stool samples over a few weeks to see if the worms are gone.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
This Phase 1 trial tests how safe and tolerated orally taken Trichuris trichiura (a type of intestinal worm) eggs are in healthy adults. It aims to help researchers understand early safety and study setup before any future treatments.
Hear when a new Soil-Transmitted Helminthiasis (STH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.